Navigation Links
SuperGen to Highlight Oncology Pipeline Data in Multiple Presentations at the AACR Annual Meeting
Date:4/7/2008

DUBLIN, Calif., April 7, 2008 /PRNewswire-FirstCall/ -- SuperGen Inc. (Nasdaq: SUPG), a pharmaceutical company dedicated to the discovery, rapid development and commercialization of therapies for solid tumors and hematological malignancies, today announced that multiple abstracts have been accepted for oral and poster presentations at the AACR Annual Meeting, which will take place April 12-16 in San Diego, California.

An oral presentation by Dr. Steven Warner will highlight SuperGen's PIM Kinase Inhibitor in cell lines from hematological and solid malignancies. The poster presentations will focus on data concerning many of SuperGen's current oncology programs, including the lead clinical compound, MP-470, and its ability to suppress the repair of double stranded DNA breaks following treatment with DNA-damaging agents.
SuperGen's schedule of presentations is as follows:

Date Time (PDT) Abstract # and Title

Sunday, 8 a.m. - 12 p.m. #671 -- Inhibition of erlotinib resistance

April 13 on HER-family tyrosine kinases by

combination with MP-470, a

multi-targeted TK inhibitor in prostate and

breast cancer

Monday, 1 p.m. - 5 p.m. #2613 -- The dinucleotide prodrug of

April 14 decitabine demonstrated increased in vivo

efficacy due to enhanced drug delivery and

stability

Tuesday, 8 a.m. - noon #4083 -- MP-470, a potent oral Rad51

April 15 suppressor is safe and tolerable in


'/>"/>

SOURCE SuperGen Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. SuperGen Reports Initiation of Multi-arm Phase 1b Trial of Novel Tyrosine Kinase Inhibitor
2. Data Support use of SuperGens CLIMB Technology in Lead Development and Optimization
3. SuperGens Novel Hypomethylating Agent Highlighted at AACR Plenary Session
4. International ACTEMRA Rheumatoid Arthritis Study Highlighted in The Lancet
5. Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights
6. Mayo Clinic Proceedings Contributors Highlight Research Findings About Cardiovascular Benefits Associated With Omega-3 Fatty Acids
7. Sarasotas Roskamp Institute Highlights Positive Japanese Data that Validates its Ongoing Alzheimers Disease Research
8. Research Highlights Potential Benefits of Telemedicine in Treating Eye Disease
9. Mitchell, Military TBI Task Force Highlight the Importance of Traumatic Brain Injury Research; Mitchell Endorses Ground Breaking Traumatic Brain Injury Study
10. Synvista Therapeutics Highlights New Data Demonstrating the Clinical Benefit of Vitamin E Therapy in Patients Identified on the Basis of Haptoglobin Phenotype Testing
11. Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2008)... BETHESDA, Md., Aug. 18 /...ical company developing novel, proprietary,antibod...autoimmune,diseases, will host a webcast and confe...at 10:00 a.m. Eastern Time (4:00 p.m. Central Euro...ere published in the Journal,SCIENCE on August 15,...
(Date:8/14/2008)... PRINCETON, N.J., Aug. 14 /PRNewswire-FirstCall/...stage pharmaceutical company committed to,discover... treat viral,infections, reported unaudited financ...e 30, 2008. Pharmasset reported a net loss attribu...a loss per share of $0.69 for the,quarter ended Ju...
(Date:8/13/2008)... Provides risk managers with comprehensive overvi...posure and required coverage, CHICAGO, Aug. 13 /P...,technology arm of Aon Corporation (NYSE: AOC ) a...ce solutions, today announced it has launched a ne...he market-leading,browser-based risk management i...
(Date:8/13/2008)... Reduction of CRP with ISIS 353512 could provide ...renal and inflammatory diseases, CARLSBAD, Calif....ticals, Inc. (Nasdaq: ISIS ) announced today it h...tisense drug that inhibits the,production of C-rea...vated,in patients with a variety of diseases inclu...
Breaking Medicine Technology:Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Published in SCIENCE 2Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Published in SCIENCE 3Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Published in SCIENCE 4Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 2Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 3Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 4Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 5Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 6Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 7Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 8Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 9Aon eSolutions Launches Clinical Trials Module 2Aon eSolutions Launches Clinical Trials Module 3Aon eSolutions Launches Clinical Trials Module 4Isis Initiates Clinical Trial of CRP Drug 2Isis Initiates Clinical Trial of CRP Drug 3WuXi PharmaTech 28NYSE 3A WX 29 Promotes Edward Hu to COO 2442 1WuXi PharmaTech 28NYSE 3A WX 29 Promotes Edward Hu to COO 2442 2Pharmos Corporation Announces Board and Management Changes 2440 1Pharmos Corporation Announces Board and Management Changes 2440 2Pharmos Corporation Announces Board and Management Changes 2440 3Biodel Inc Completes Enrollment of Two Pivotal Phase III Clinical Trials of VIAject 28TM 29 and Plans Manufacturing Facility for VIAject 28TM 29 1136 1Biodel Inc Completes Enrollment of Two Pivotal Phase III Clinical Trials of VIAject 28TM 29 and Plans Manufacturing Facility for VIAject 28TM 29 1136 2Biodel Inc Completes Enrollment of Two Pivotal Phase III Clinical Trials of VIAject 28TM 29 and Plans Manufacturing Facility for VIAject 28TM 29 1136 3Takeda Submits New Drug Application for Alogliptin 28SYR 322 29 in the U S 1134 1Takeda Submits New Drug Application for Alogliptin 28SYR 322 29 in the U S 1134 2Takeda Submits New Drug Application for Alogliptin 28SYR 322 29 in the U S 1134 3Takeda Submits New Drug Application for Alogliptin 28SYR 322 29 in the U S 1134 4
...ss.--(BUSINESS WIRE)--Mar 14, 2007 - ArQule, Inc.,...ociety of,Clinical Oncology (ASCO) has accepted fo... 197 (A Phase 1 Dose Escalation Study of,ARQ 197, ...ients,with Metastatic Solid Tumors) at the 43rd AS...s presentation will describe findings,from a Phase...
...lough Announces Presentation Of Phase II Trial Res...t The 2007 Annual,Meeting Of The American College ...6, 2007 /PRNewswire-FirstCall/ --,Schering-Plough ...ase II trial of its novel oral thrombin receptor a...e 2007 annual Scientific Sessions,of the of Cardio...
Other Medicine Technology:ArQule Announces Acceptance of Clinical Data on ARQ 197, c-Met,Inhibitor, for Oral Presentation at ASCO 2ArQule Announces Acceptance of Clinical Data on ARQ 197, c-Met,Inhibitor, for Oral Presentation at ASCO 3ArQule Announces Acceptance of Clinical Data on ARQ 197, c-Met,Inhibitor, for Oral Presentation at ASCO 4Media Advisory: ACC Updated Schedule 2
(Date:8/20/2008)...usetts General Hospital (MGH) investigators have f...em cell appeared to protect gastrointestinal tissu...ir report published in the journal Stem Cells , t...icine report that mesenchymal stem cells (MSCs), k...allowed the regeneration of the gastrointestinal l...
(Date:8/20/2008)...NGTON, Aug. 20 /PRNewswire-USNewswire/ -- Yesterda... admitted to Huron Hospital after,suffering an ane...Ohio. At,the present time Rep. Tubbs Jones, condit...are available., Tuesday,s condition followed a fu...ming forum on electoral reform, scheduled for Sept...
(Date:8/20/2008)... Micro(R) PUMP and ELLEgirl.com Send Four Girls to...Summer, LOS ANGELES, Aug. 20 /PRNewswire/ -- Reti...eenage Web site ELLEgirl.com to send four contest,...Camp in Santa Monica,California. With the new sch...mpower girls to become successful women by helping...
(Date:8/20/2008)...IEGO, Aug. 20 /PRNewswire/ --You,re late for work,...r car won,t start. How do you deal with,the rising...ash out in,frustration, how you deal with anger af...r children and even your career., As hard as we m...push,our buttons. While feeling anger isn,t a bad ...
Breaking Medicine News(10 mins):Health News:Bone marrow stem cells may help control inflammatory bowel disease 2Health News:Bone marrow stem cells may help control inflammatory bowel disease 3Health News:Special Summer Camp Helps Girls Recognize Inner and Outer Beauty 2Health News:Special Summer Camp Helps Girls Recognize Inner and Outer Beauty 3Health News:Special Summer Camp Helps Girls Recognize Inner and Outer Beauty 4Health News:Special Summer Camp Helps Girls Recognize Inner and Outer Beauty 5Health News:Taming Your Temper: Learning to Turn Down the Heat 2
...MA today criticises a recommendation from the Depa...should receive below-inflation pay rises//. In its...Review Body, published today, the government argue... of 1.5%. In its own evidence to the Review Body,...
...e has claimed four lives in West Bengal and affect...sra said Thursday//. "There are four deaths so far...ra. City Mayor Bikash Bhattacharya had said earli...e in Kolkata were affected by dengue with one deat...
...ise in the number of chemotherapy patients has inc... people are requested to donate platelets.// Acco...he Irish Cancer Society (ICS), in the last 5 years...d for blood components due to the growing number o...
...a has more than 16% of its population which is est...e ravages of the deadly scourge AIDS.// It is how...has made considerable progress in keeping the HIV ...to the notice of the US government. In appreciatio...
Other Medicine News:Health News:Chemotherapy increases the demand for blood components 2
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
Medicine Products: